Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Clinical Colorectal Cancer|June 7, 2024
VIC Regimen (Vemurafenib/Irinotecan/Cetuximab) Versus Bevacizumab Plus Chemotherapy as First-Line Treatment for BRAF V600E-Mutated Unresectable or Metastatic Colorectal Cancer in Asian Patients: A Prospective Cohort StudyYijiao Chen, Dexiang Zhu, Yiyi Yu, et al.
Clinical Colorectal Cancer|September 20, 2023
Impact of Surgical Management for Relapse After Conversion Hepatectomy for Initially Unresectable Colorectal Liver Metastasis: A Retrospective Cohort StudyYijiao Chen, Dexiang Zhu, Miao Chen, et al.
Clinical Medicine Insights. Oncology|March 28, 2022
No.253 Lymph Nodes Metastasis in Left-Sided Colorectal Cancer Liver Metastasis (CRLM) Patients: Incidence and PrognosisJiang Chang, Yihao Mao, Qingyang Feng, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 29, 2014
Aberrant expression of sphingosine-1-phosphate receptor 1 correlates with metachronous liver metastasis and poor prognosis in colorectal cancerQi Lin, Ye Wei, Yunshi Zhong, et al.
Cancer Management and Research|October 2, 2018
Low tumor purity is associated with poor prognosis, heavy mutation burden, and intense immune phenotype in colon cancerYihao Mao, Qingyang Feng, Peng Zheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2019
Tumor-associated Macrophages as Prognostic and Predictive Biomarkers for Postoperative Adjuvant Chemotherapy in Patients with Stage II Colon CancerQingyang Feng, Wenju Chang, Yihao Mao, et al.
International Immunopharmacology|March 2, 2024
Siglec9 + tumor-associated macrophages predict prognosis and therapeutic vulnerability in patients with colon cancerJiang Chang, Qingyang Feng, Yihao Mao, et al.
Oncotarget|February 11, 2016
Efficacy of continued cetuximab for unresectable metastatic colorectal cancer after disease progression during first-line cetuximab-based chemotherapy: a retrospective cohort studyQingyang Feng, Ye Wei, Li Ren, et al.
Frontiers in Immunology|August 29, 2022
The immune phenotypes and different immune escape mechanisms in colorectal cancerYihao Mao, Yuqiu Xu, Jiang Chang, et al.
JAMA|June 2, 2025
Robotic vs Laparoscopic Surgery for Middle and Low Rectal Cancer: The REAL Randomized Clinical TrialQingyang Feng, Weitang Yuan, Taiyuan Li, et al.
Pageof 6